Utility of endometrial sampling prior to risk-reducing hysterectomy in a patient with Lynch syndrome

被引:3
作者
Frey, Melissa K. [1 ]
David-West, Gizelka [1 ]
Mittal, Khushbakhat R. [2 ]
Muggia, Franco M. [3 ]
Pothuri, Bhavana [1 ]
机构
[1] NYU, Dept Obstet & Gynecol, Langone Med Ctr, Div Gynecol Oncol, New York, NY 10016 USA
[2] NYU, Dept Pathol, Langone Med Ctr, 550 1St Ave, New York, NY 10016 USA
[3] NYU, Dept Med, Langone Med Ctr, 550 1St Ave, New York, NY 10016 USA
来源
ECANCERMEDICALSCIENCE | 2016年 / 10卷
关键词
colorectal neoplasms; hereditary nonpolyposis; endometrial neoplasms; hysterectomy; risk reduction surgery; uterine neoplasms;
D O I
10.3332/ecancer.2016.613
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Occult endometrial cancer is occasionally discovered in women with Lynch syndrome undergoing risk-reducing hysterectomy. The case presented here demonstrates that preoperative endometrial sampling can help detect these occult cancers; however, there are currently no recommendations for this preoperative intervention. A 50-year-old woman with Lynch syndrome underwent endometrial sampling prior to planned risk-reducing hysterectomy and bilateral salpingo-oophorectomy. The endometrial biopsy demonstrated a serous endometrial cancer. The patient was counselled regarding the diagnosis and revised operative plan, which now included staging, prior to surgery. Although the prevalence of occult endometrial cancer at the time of risk-reducing surgery in women with Lynch syndrome remains unknown, preoperative endometrial sampling may allow for improved patient counselling and surgical planning in this population, and can help avoid a subsequent surgery for staging.
引用
收藏
页数:4
相关论文
共 10 条
  • [1] Quality of Life after Risk-Reducing Hysterectomy for Endometrial Cancer Prevention: A Systematic Review
    Oxley, Samuel
    Xiong, Ran
    Wei, Xia
    Kalra, Ashwin
    Sideris, Michail
    Legood, Rosa
    Manchanda, Ranjit
    CANCERS, 2022, 14 (23)
  • [2] Screening and risk reducing surgery for endometrial or ovarian cancers in Lynch syndrome: a systematic review
    Lim, Natalie
    Hickey, Martha
    Young, Graeme P.
    Macrae, Finlay A.
    Kelly, Christabel
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 (05) : 646 - 655
  • [3] Risk-reducing surgery in hereditary gynecological cancer: Clinical applications in Lynch syndrome and hereditary breast and ovarian cancer (Review)
    Adachi, Masataka
    Banno, Kouji
    Yanokura, Megumi
    Lida, Miho
    Nakamura, Kanako
    Nogami, Yuya
    Umene, Kiyoko
    Masuda, Kenta
    Kisu, Iori
    Ueki, Arisa
    Hirasawa, Akira
    Tominaga, Eiichiro
    Aoki, Daisuke
    MOLECULAR AND CLINICAL ONCOLOGY, 2015, 3 (02) : 267 - 273
  • [4] Assessing Effectiveness of Colonic and Gynecological Risk Reducing Surgery in Lynch Syndrome Individuals
    Duenas, Nuria
    Navarro, Matilde
    Teule, Alex
    Solanes, Ares
    Salinas, Monica
    Iglesias, Silvia
    Munte, Elisabet
    Ponce, Jordi
    Guardiola, Jordi
    Kreisler, Esther
    Carballas, Elvira
    Cuadrado, Marta
    Matias-Guiu, Xavier
    de la Ossa, Napoleon
    Lop, Joan
    Lazaro, Conxi
    Capella, Gabriel
    Pineda, Marta
    Brunet, Joan
    CANCERS, 2020, 12 (11) : 1 - 17
  • [5] Prophylactic Risk-reducing Hysterectomies and Bilateral Salpingo-oophorectomies in Patients With Lynch Syndrome: A Clinicopathologic Study of 29 Cases and Review of the Literature
    Fedda, Faysal A.
    Euscher, Elizabeth D.
    Ramalingam, Preetha
    Malpica, Anais
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2020, 39 (04) : 313 - 320
  • [6] Analyzing 10-year time trends for Hysterectomy and Oophorectomy: Focus on Endometrial sampling and risk factors for Endometrial Cancer
    Yurtkal, Aslihan
    Canday, Mujde
    MALAWI MEDICAL JOURNAL, 2024, 36 (02) : 144 - 153
  • [7] Use of total abdominal hysterectomy and hormone replacement therapy in BRCA1 and BRCA2 mutation carriers undergoing risk-reducing salpingo-oophorectomy
    C. A. Gabriel
    J. Tigges-Cardwell
    J. Stopfer
    J. Erlichman
    K. Nathanson
    S. M. Domchek
    Familial Cancer, 2009, 8 : 23 - 28
  • [8] Use of total abdominal hysterectomy and hormone replacement therapy in BRCA1 and BRCA2 mutation carriers undergoing risk-reducing salpingo-oophorectomy
    Gabriel, C. A.
    Tigges-Cardwell, J.
    Stopfer, J.
    Erlichman, J.
    Nathanson, K.
    Domchek, S. M.
    FAMILIAL CANCER, 2009, 8 (01) : 23 - 28
  • [9] Mortality reduction and cost-effectiveness of performing hysterectomy at the time of risk-reducing salpingo-oophorectomy for prophylaxis against serous/serous-like uterine cancers in BRCA1 mutation carriers
    Havrilesky, Laura J.
    Moss, Haley A.
    Chino, Junzo
    Myers, Evan R.
    Kauff, Noah D.
    GYNECOLOGIC ONCOLOGY, 2017, 145 (03) : 549 - 554
  • [10] Excellent long-term survival and absence of vaginal recurrences in 332 patients with low-risk Stage I endometrial adenocarcinoma treated with hysterectomy and vaginal brachytherapy without formal staging lymph node sampling: Report of a prospective trial
    Eltabbakh, GH
    Piver, MS
    Hempling, RE
    Shin, KH
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 38 (02): : 373 - 380